|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2.260 USD | +3.20% |
|
-4.24% | +38.65% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 428M | - | - | - | ||
| 68.92B | |||||
| 51.9B | |||||
| 48.73B | |||||
| 43.13B | |||||
| 41.48B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
